| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 404,770 | 299,580 | 343,470 | 296,427 | | Cost of Revenue | 221,648 | 176,373 | 218,041 | 203,061 | | | Gross Profit | 183,122 | 123,207 | 125,429 | 93,366 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 151,699 | 130,933 | 119,276 | 130,914 | | Non Recurring |
-
|
-
|
-
| (2,461) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 32,445 | (7,726) | 6,153 | (35,087) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 3,520 | 829 | 488 | 1,627 | | Earnings Before Interest And Taxes | 34,943 | (6,897) | 6,641 | (33,460) | | Interest Expense | 987 | 915 | 42 | 990 | | Income Before Tax | 33,956 | (7,812) | 6,599 | (34,450) | | Income Tax Expense | 10,175 | (1,186) | (753) | (12,917) | | Minority Interest | 679 | 699 | 868 | 1,155 | | | | Net Income From Continuing Ops | 24,460 | (5,927) | 8,220 | (20,378) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 24,460 | (5,927) | 8,220 | (20,378) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $24,460 | ($5,927) | $8,220 | ($20,378) |
|
0.51% Nasdaq 
Income Statement
